Alnylam Pharmace. buy RudolfL
Start price
19.11.19
/
50%
€88.35
Target price
04.11.21
€140.00
Performance (%)
15.29%
End price
10.12.20
€101.86
Summary
This prediction ended on 10.12.20 with a price of €101.86. The prediction had a final performance of 15.29%. RudolfL has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | -4.475% | -4.475% | -26.571% | 18.799% |
| iShares Core DAX® | -0.870% | -1.700% | 10.560% | 13.129% |
| iShares Nasdaq 100 | -5.561% | -3.604% | 34.335% | 39.856% |
| iShares Nikkei 225® | -6.138% | -7.732% | 16.215% | 0.044% |
| iShares S&P 500 | -3.141% | -2.011% | 24.534% | 39.859% |
Comments by RudolfL for this prediction
In the thread Alnylam Pharmace. diskutieren
Buy mit Kursziel 115,0
Kursziel geändert auf 127,0
Kursziel geändert auf 140,0